ArticleBriefings in bioinformatics2025
Mutual-assistance learning for trustworthy biomarker discovery and disease prediction.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Integrating and analyzing multiple omics datasets, such as genomics, environmental influences, and imaging endophenotypes, has yielded an abundance of candidate biomarkers. However, translating such findings into beneficial clinical knowledge for disease prediction remains challenging. This becomes even more challenging when studying interpretable high-order feature interactions such as gene-environment interaction (G$\times $E) to understand the etiology. To fill this gap, we draw on the idea of mutual-assistance (MA) learning and accordingly propose a fresh and powerful scheme, referred to as mutual-assistance causal biomarker discovery and stable disease prediction approach (MA-CBxDP). Specifically, we design an interpretable bi-directional mapping framework, integrated with a causal feature interaction module, to extract co-expression patterns across different modalities and identify trustworthy biomarkers including G$\times $E. A cooperative prediction module is further incorporated to ensure accurate diagnosis and identification of causal effects for pathogenesis. Importantly, biomarker discovery and disease prediction can mutually reinforce each other, helping to provide novel insights into chronic diseases. Furthermore, in light of the large computational burden incurred by the high-dimensional interactions, we devise a rapid strategy and extend it to a more practical but challenging chromosome-wide setting. We conduct extensive experiments on two databases under three tasks, i.e. multimodal correlation, disease diagnosis, and trait prediction. MA-CBxDP establishes new state-of-the-art results in predicting clinical scores and disease status classification, while maintaining exceptional interpretability, verifying its flexibility and versatility in practical applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.